FST JOURNAL

Recent developments have shown the potential for Artificial Intelligence in the early detection of diseases such as cancer, Alzheimer's and retinal diseases. What is the current state of this technology in medical science? How widespread is its application? What will this mean for clinicians and patients? Are there particular ethical implications and how should the use of this rapidly evolving technology be regulated?

To explore these questions, the Foundation for Science and Technology brought together a number of specialists in this area at a meeting held at the Royal Society on 14 June 2023. The audience heard from David Crosby, Head of Prevention and Early Detection Research, Cancer Research UK; Mike Oldham, at the time Director of Early Detection of Neurodegenerative Diseases, Alzheimer's Research UK; Jessica Morley of the Oxford Internet Institute, University of Oxford; and Tobias Rijken, Co-Founder and Chief Technology Officer, Kheiron Medical Technologies. A video recording, presentation slides and speaker audio from the event can be found on the Foundation website at: www.foundation.org.uk/Events/2023/The-use-of-AI-in-the-early-detection-of-disease